Pembrolizumab May Be Preferable to Chemo in Certain Patients
NEW YORK (Reuters Health) – Pembrolizumab may have an edge on chemotherapy for microsatellite instability-high (MSI-H) advanced gastric or gastroesophageal-junction […]
NEW YORK (Reuters Health) – Pembrolizumab may have an edge on chemotherapy for microsatellite instability-high (MSI-H) advanced gastric or gastroesophageal-junction […] (Reuters) – COVID-19 was the primary or contributing cause of 378,048 deaths in the United States last year, with a […] (Reuters Health) – Asian-American adults are significantly less likely to consistently use sunscreen than non-Hispanic whites, a new U.S. study […] NEW YORK (Reuters Health) – Radiofrequency ablation (RFA) for the palliative treatment of patients whose cancer has spread to the […] NEW YORK (Reuters Staff) – Using serum metabolomics profiling, researchers have identified two metabolites that are associated with risk for […] NEW YORK (Reuters Health) – Dose-intensified salvage radiotherapy is not superior to conventional dose salvage RT and is associated with […]malignant neoplasm
Pembrolizumab May Be Preferable to Chemo in Certain Patients
COVID-19 Third Leading Cause of US Deaths in 2020 After Heart Disease, Cancer: MMWR
Asian-Americans Less Likely to Use Sunscreen Than Non-Hispanic Whites
Radiofrequency Ablation Provides Fast Relief of Painful Bone Tumors
Serum Biomarkers of Increased Risk for Second Primary Lung Cancer Identified
No Benefit of Dose-Intensified Salvage Radiation for Prostate Cancer Recurrence
Copyright © 2024